Thomas Civik - Interim CEO, Director at Pyxis Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO, Director
Issuer Symbol
PYXS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Civik since 13 Feb 2025

Holdings reported by Thomas Civik for Pyxis Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 690,131 $36,239 $0.9800 03 Feb 2026 Direct Common Stock

Transactions reported by Thomas Civik for Pyxis Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.